HHLR ADVISORS, LTD.
SuperinvestorHHLR Advisors (Hillhouse)
- SEC CIK
- 0001762304
- Manager
- Zhang Lei
- Style
- Growth
NBP holding history
NovaBridge Biosciences
Every 13F filing in which HHLR Advisors (Hillhouse) reported holding NBP, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
NBP overviewAll 13F holders of NBPFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 5,980,568 | $11.66M | 1.40% | 00.0% | Unchanged |
| Q1 2026 | 5,980,568 | $14.71M | 0.88% | 00.0% | Unchanged |
| Q4 2025 | 5,980,568 | $23.8M | 0.77% | 00.0% | Unchanged |
| Q3 2025 | 5,980,568 | $22.61M | 0.55% | 00.0% | Unchanged |
| Q2 2025 | 5,980,568 | $14.47M | 0.47% | 00.0% | Unchanged |
| Q1 2025 | 5,980,568 | $4.93M | 0.14% | 00.0% | Unchanged |
| Q4 2024 | 5,980,568 | $5.08M | 0.18% | −928,652−13.4% | Reduced |
| Q3 2024 | 6,909,220 | $8.57M | 0.19% | 00.0% | Unchanged |
| Q2 2024 | 6,909,220 | $11.54M | 0.28% | 00.0% | Unchanged |
| Q1 2024 | 6,909,220 | $12.85M | 0.28% | 00.0% | Unchanged |
| Q4 2023 | 6,909,220 | $13.13M | 0.26% | 00.0% | Unchanged |
| Q3 2023 | 6,909,220 | $9.12M | 0.20% | 00.0% | Unchanged |
| Q2 2023 | 6,909,220 | $20.66M | 0.44% | −45,222−0.7% | Reduced |
| Q1 2023 | 6,954,442 | $24.06M | 0.43% | −228,408−3.2% | Reduced |
| Q4 2022 | 7,182,850 | $30.02M | 0.63% | 00.0% | Unchanged |
| Q3 2022 | 7,182,850 | $28.8M | 0.76% | 00.0% | Unchanged |
| Q2 2022 | 7,182,850 | $81.17M | 1.74% | 00.0% | Unchanged |
| Q1 2022 | 7,182,850 | $116.65M | 2.44% | 00.0% | Unchanged |
| Q4 2021 | 7,182,850 | $340.4M | 5.26% | 00.0% | Unchanged |
| Q3 2021 | 7,182,850 | $520.69M | 6.81% | +566,680+8.6% | Added |
| Q2 2021 | 6,616,170 | $555.43M | 5.72% | 00.0% | Unchanged |
| Q1 2021 | 6,616,170 | $320.69M | 3.17% | +6,616,170 | New |